As cited by the research report titled ‘Global Inhaled Nitric Oxide (iNO) Market a?? Analysis By Product Type, Application (ARDS, PPHN, Others), By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)’, available with Market Study Report, global inhaled nitric oxide (iNO) market amassed USD 830.8 million in 2019 and is projected to expand significantly during 2020 to 2025.
 

Increasing demand from healthcare units, research & development activities resulting into innovative applications in healthcare vertical, and ascending pollution levels leading to health issues are the major factors driving the global inhaled nitric oxide (iNO) market growth. Furthermore, high per capita expenditure on healthcare, rising number of hospitals, shifting preference for branded treatments & drugs, and high research funding are enhancing the market progression.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2752219/
 

Additionally, with booming elderly populace, there is increased prevalence of respiratory tract infections, chronic obstructive pulmonary diseases, tuberculosis, bronchial asthma, and several other diseases, thus fueling the industry demand. Moreover, various innovative technologies like LungFit device by Beyond Air Inc., which is simple, cylinder free, plasma arc discharge-based technology, is positively swaying the industry dynamics.
 

Based on product type, worldwide inhaled nitric oxide (iNO) industry is segmented into 99.92% purity, and 99.99% purity among others. Among these, 99.92% purity product segment is anticipated to hold a significant market share over the forecast period.
 

Speaking of application ambit, the marketplace is divided into acute respiratory distress syndrome (ARDS), and persistent pulmonary hypertension in the newborn (PPHN), including others.
 

Geographically, Asia Pacific (China, Japan, India), Europe (Germany, United Kingdom, Italy, France), and North America (United States, Canada, Mexico) are major contributors to the overall inhaled nitric oxide (iNO) industry value, cites the report. Of these, North America holds a considerable market share and is poised to showcase lucrative growth trends over the forecast duration, on account of large consumer base, and growing investment in research & development by prominent players in the region.
 

Lastly, the report consolidates business profiles of established contenders like Novoteris LLC, Nu-Med Plus Inc., Beyond Air Inc., Vero Biotech LLC, Linde Plc (Praxair Inc.), Air Liquide S.A., and Mallinckrodt Pharmaceuticals to provide better insights into the competitive framework of the market.